The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Effect of food on exposure to napabucasin: Data from two phase I studies.

Xiaoshu  Dai

Employment - Sumitomo Dainippon Pharma Oncology

Naoto  Noda

Employment - Sumitomo Dainippon Pharma Oncology

Yuran  Xie

Employment - Sumitomo Dainippon Pharma Oncology

Travel, Accommodations, Expenses - Sumitomo Dainippon Pharma Oncology

Bo  Xu

Employment - Sumitomo Dainippon Pharma Oncology

Matthew  Hitron

Employment - Sumitomo Dainippon Pharma Oncology

Leadership - Sumitomo Dainippon Pharma Oncology

Michael  Karol

Employment - Sarepta Therapeutics (I); Sumitomo Group

Stock and Other Ownership Interests  - Abbott/AbbVie